Pharmacovigilance (PV) plays a key role in the healthcare system through assessment, monitoring and discovery of interactions amongst drugs and their effects in human. Pharmaceutical and biotechnological medicines are designed to cure, prevent or treat diseases; however, there are also risks particularly adverse drug reactions (ADRs) that can cause serious harm to patients. Thus, for medication safety,  ADRs monitoring is required for each medicine throughout its life cycle, during development of drug such as pre-marketing including early stages of drug design, clinical trials, and post-marketing surveillance. PV is concerned with the detection, assessment, understanding and prevention of ADRs

If you witness any kind of ADRs related to our medications, kindly e-mail us on the following email address: